Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03184454 · ClinicalTrials.gov registry record · NA
Combined Cortical/Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder
A NA study of Obsessive - Compulsive Disorder, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 2
- Study locations
NCT03184454: Active NA study of Obsessive - Compulsive Disorder, sponsored by Massachusetts General Hospital.
NCT03184454 is a NA study of Obsessive - Compulsive Disorder that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 2 participants, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03184454, a NA study of Obsessive - Compulsive Disorder, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study involves the use of the Medtronic PC+S deep brain stimulation for the treatment of intractable OCD.
Primary Outcome
The Yale-Brown Obsessive-Compulsive Scale (YBOCS) will be the principal outcome measure for tracking OCD symptoms. We will collect this measure at all clinical visits.
Conditions Studied
Interventions
- DEVICE Medtronic Percept Deep Brain Stimulation
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Charlestown
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What the registry record for NCT03184454 still lists
NCT03184454 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Medtronic Percept Deep Brain Stimulation is the first listed.
NCT03184454 reports a single indexed study location in Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03184454 about?
NCT03184454 is a clinical study titled "Combined Cortical/Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder". This study involves the use of the Medtronic PC+S deep brain stimulation for the treatment of intractable OCD.
What is the current status of trial NCT03184454?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 2 participants. The study started on 2019-03-01. Estimated completion is 2026-10-31.
What conditions does trial NCT03184454 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.
What interventions are being tested in trial NCT03184454?
The interventions under investigation include: Medtronic Percept Deep Brain Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03184454?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03184454 being conducted?
This trial has 2 study locations across Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03184454's enrollment target sits among peer trials
2 84th of 84 the lowest of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Interpretation Bias as a Mechanism of Treatment Response in OCD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI